{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:40Z","timestamp":1786982860644,"version":"build-2736575974"},"reference-count":232,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374285"],"award-info":[{"award-number":["82374285"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"State Administration of Traditional Chinese Medicine of the People's Republic of China","doi-asserted-by":"publisher","award":["202305350013"],"award-info":[{"award-number":["202305350013"]}],"id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["XJ2023000701"],"award-info":[{"award-number":["XJ2023000701"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40744-026-00865-y","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T16:37:26Z","timestamp":1780763846000},"page":"951-984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fatigue in Sj\u00f6gren\u2019s Disease\u00a0- Integrating Biomedical and Psychosocial Aspects: A Narrative Review"],"prefix":"10.1007","volume":"13","author":[{"given":"Xinyao","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5131-5043","authenticated-orcid":false,"given":"Jinzhou","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Cathebras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-3248","authenticated-orcid":false,"given":"Martin","family":"Killian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"9","key":"865_CR1","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.1016\/S2665-9913(24)00039-0","volume":"6","author":"S Gandolfo","year":"2024","unstructured":"Gandolfo S, Bombardieri M, Pers JO, Mariette X, Ciccia F. Precision medicine in Sj\u00f6gren\u2019s disease. Lancet Rheumatol. 2024;6(9):e636\u201347. https:\/\/doi.org\/10.1016\/S2665-9913(24)00039-0.","journal-title":"Lancet Rheumatol"},{"issue":"6","key":"865_CR2","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror R, Ravaud P, Mariette X, Bootsma H, Theander E, Hansen A,\u00a0et al. EULAR Sj\u00f6gren\u2019s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2011;70(6):968\u201372. https:\/\/doi.org\/10.1136\/ard.2010.143743.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"865_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-021-00181-9","volume":"61","author":"LH Dias","year":"2021","unstructured":"Dias LH, Miyamoto ST, Giovelli RA, de Magalh\u00e3es CIM, Valim V. Pain and fatigue are predictors of quality of life in primary Sj\u00f6gren\u2019s syndrome. Adv Rheumatol. 2021;61(1):28. https:\/\/doi.org\/10.1186\/s42358-021-00181-9.","journal-title":"Adv Rheumatol"},{"key":"865_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.703079","volume":"12","author":"E M\u00e6land","year":"2021","unstructured":"M\u00e6land E, Miyamoto ST, Hammenfors D, Valim V, Jonsson MV. Understanding fatigue in Sj\u00f6gren\u2019s syndrome: outcome measures, biomarkers and possible interventions. Front Immunol. 2021;12:703079. https:\/\/doi.org\/10.3389\/fimmu.2021.703079.","journal-title":"Front Immunol"},{"issue":"9","key":"865_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-023-07967-1","volume":"31","author":"J Li","year":"2023","unstructured":"Li J, Fu R, Guo X, Pan Z, Xie J. Acupuncture improves immunity and fatigue after chemotherapy in breast cancer patients by inhibiting the leptin\/AMPK signaling pathway. Support Care Cancer. 2023;31(9):506. https:\/\/doi.org\/10.1007\/s00520-023-07967-1.","journal-title":"Support Care Cancer"},{"issue":"1","key":"865_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-10805-5","volume":"15","author":"J Kang","year":"2025","unstructured":"Kang J, Zhao X, Zheng Z, Tian Y, Tian W, Miao X. An investigation of post-stroke fatigue levels and influencing factors in young and middle-aged stroke patients: a cross-sectional study. Sci Rep. 2025;15(1):25046. https:\/\/doi.org\/10.1038\/s41598-025-10805-5.","journal-title":"Sci Rep"},{"issue":"15","key":"865_CR7","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.70485","volume":"13","author":"AM Wafi","year":"2025","unstructured":"Wafi AM, Gao L, Zucker IH. Blood lactate as a marker of exercise adaptation and fatigue in male mice with chronic heart failure. Physiol Rep. 2025;13(15):e70485. https:\/\/doi.org\/10.14814\/phy2.70485.","journal-title":"Physiol Rep"},{"key":"865_CR8","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaf116","author":"MM Ter Avest","year":"2025","unstructured":"Ter Avest MM, Huijbers MJ, Horjus CS, et al. Group-delivered mindfulness-based cognitive therapy to reduce psychological distress and improve sleep in patients with inflammatory bowel diseases: a multicenter randomized controlled trial (MindIBD). Inflamm Bowel Dis. 2025. https:\/\/doi.org\/10.1093\/ibd\/izaf116.","journal-title":"Inflamm Bowel Dis"},{"key":"865_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103899","author":"M Camard","year":"2025","unstructured":"Camard M, Urbain F, Noel N. Cognitive impairment in systemic autoimmune and inflammatory diseases: a narrative review focused on ANCA-associated vasculitis, sarcoidosis, Sj\u00f6gren\u2019s syndrome, systemic sclerosis, and Beh\u00e7et\u2019s disease. Autoimmun Rev. 2025. https:\/\/doi.org\/10.1016\/j.autrev.2025.103899.","journal-title":"Autoimmun Rev"},{"issue":"11","key":"865_CR10","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41584-021-00692-1","volume":"17","author":"K Davies","year":"2021","unstructured":"Davies K, Dures E, Ng WF. Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research. Nat Rev Rheumatol. 2021;17(11):651\u201364. https:\/\/doi.org\/10.1038\/s41584-021-00692-1.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"865_CR11","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000541741","volume":"94","author":"B L\u00f6we","year":"2025","unstructured":"L\u00f6we B, Zipfel S, van den Bergh O, Henningsen P.\u00a0Reconsidering persistent somatic symptoms: a transdiagnostic and transsymptomatic approach. Psychother Psychosom. 2025;94(1):20\u20135. https:\/\/doi.org\/10.1159\/000541741.","journal-title":"Psychother Psychosom"},{"issue":"10444","key":"865_CR12","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/S0140-6736(24)00623-8","volume":"403","author":"B L\u00f6we","year":"2024","unstructured":"L\u00f6we B, Toussaint A, Rosmalen JGM, et al. Persistent physical symptoms: definition, genesis, and management. Lancet. 2024;403(10444):2649\u201362. https:\/\/doi.org\/10.1016\/S0140-6736(24)00623-8.","journal-title":"Lancet"},{"key":"865_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjsem-2025-002677","volume":"11","author":"X Zhou","year":"2025","unstructured":"Zhou X, Chen J, Colas C, Hupin D, Killian M. Fatigue in Sj\u00f6gren\u2019s syndrome: a randomised controlled trial of combined non-pharmacological therapeutic strategies (FESSONA). BMJ Open Sport Exerc Med. 2025;11:e002677. https:\/\/doi.org\/10.1136\/bmjsem-2025-002677.","journal-title":"BMJ Open Sport Exerc Med"},{"key":"865_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2025.2474085","author":"NE Nacar","year":"2025","unstructured":"Nacar NE, Karaborklu Argut S, Unal E. Effects of exercise in primary Sj\u00f6gren\u2019s syndrome: a systematic review and meta-analysis of randomized clinical trials. Disabil Rehabil. 2025. https:\/\/doi.org\/10.1080\/09638288.2025.2474085.","journal-title":"Disabil Rehabil"},{"key":"865_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.878218","volume":"9","author":"X Zhou","year":"2022","unstructured":"Zhou X, Xu H, Chen J,\u00a0et al. Efficacy and safety of acupuncture on symptomatic improvement in primary Sj\u00f6gren\u2019s syndrome: a randomized controlled trial. Front Med. 2022;9:878218. https:\/\/doi.org\/10.3389\/fmed.2022.878218.","journal-title":"Front Med"},{"issue":"6","key":"865_CR16","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.3390\/jcm13061537","volume":"13","author":"DA Mardale","year":"2024","unstructured":"Mardale DA, Opri\u015f-Belinski D, Bojinc\u0103 V, et al. The physical and psychosocial impact of fatigue among patients with Sj\u00f6gren\u2019s syndrome: a systematic review. J Clin Med. 2024;13(6):1537. https:\/\/doi.org\/10.3390\/jcm13061537).","journal-title":"J Clin Med"},{"key":"865_CR17","doi-asserted-by":"publisher","first-page":"8859","DOI":"10.1093\/rheumatology\/kel021","volume":"45","author":"LC Pollard","year":"2006","unstructured":"Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology( Oxford). 2006;45:8859.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00296-013-2850-9","volume":"34","author":"KB Norheim","year":"2014","unstructured":"Norheim KB, le Hellard S, Nordmark G, et al. A possible genetic association with chronic fatigue in primary Sj\u00f6gren\u2019s syndrome: a candidate gene study. Rheumatol Int. 2014;34:191\u20137.","journal-title":"Rheumatol Int"},{"key":"865_CR19","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.ygeno.2006.06.016","volume":"88","author":"T Haitina","year":"2006","unstructured":"Haitina T, Lindblom J, Renstro\u00a8m T, Fredriksson R. Fourteen novel human members of mitochondrial solute carrier family 25 (SLC25) widely expressed in the central nervous system. Genomics. 2006;88:779\u201390.","journal-title":"Genomics"},{"key":"865_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1365-2443.2008.01182.x","volume":"13","author":"T Kato Jr","year":"2008","unstructured":"Kato T Jr, Gotoh Y, Hoffmann A, Ono Y. Negative regulation of constitutive NF-jB and JKN signaling by PKN1-mediated phosphorylation of TRAF1. Genes Cells. 2008;13:509\u201320.","journal-title":"Genes Cells"},{"key":"865_CR21","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/rheumatology\/kew008","volume":"55","author":"K Br\u00e6kke Norheim","year":"2016","unstructured":"Br\u00e6kke Norheim K, Imgenberg-Kreuz J, Jonsdottir K, et al. Epigenome-wide DNA methylation patterns associated with fatigue in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2016;55:1074\u201382.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"865_CR22","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7697558","volume":"2022","author":"G Chen","year":"2022","unstructured":"Chen G, Che L, Cai X, Zhu P, Ran J. Bioinformatic analysis identifies biomarkers and treatment targets in primary Sj\u00f6gren\u2019s syndrome patients with fatigue. BioMed Res Int. 2022;2022(1):7697558. https:\/\/doi.org\/10.1155\/2022\/7697558.","journal-title":"BioMed Res Int"},{"key":"865_CR23","doi-asserted-by":"crossref","unstructured":"Norheim KB, Imgenberg-Kreuz J, Alexsson A, et al. Genetic variants at the RTP4\/MASP1 locus are associated with fatigue in Scandinavian patients with primary Sj\u00f6gren's syndrome. RMD Open. 2021;7.","DOI":"10.1136\/rmdopen-2021-001832"},{"issue":"7","key":"865_CR24","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1093\/rheumatology\/kez027","volume":"60","author":"R Omdal","year":"2021","unstructured":"Omdal R, Mellgren SI, Norheim KB. Pain and fatigue in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2021;60(7):3099\u2013106. https:\/\/doi.org\/10.1093\/rheumatology\/kez027.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.836824","volume":"13","author":"CM Flessa","year":"2022","unstructured":"Flessa CM, Zampeli E, Evangelopoulos ME, et al. Genetic variants of the BAFF gene and risk of fatigue among patients with primary Sj\u00f6gren\u2019s Syndrome. Front Immunol. 2022;13:836824.","journal-title":"Front Immunol"},{"key":"865_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jaut.2013.04.005","volume":"51","author":"A Nezos","year":"2014","unstructured":"Nezos A, Papageorgiou A, Fragoulis G, et al. B-cell activating factor genetic variants in lymphomagenesis associated with primary Sj\u00f6gren\u2019s syndrome. J Autoimmun. 2014;51:89\u201398. https:\/\/doi.org\/10.1016\/j.jaut.2013.04.005.","journal-title":"J Autoimmun"},{"issue":"9","key":"865_CR27","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1093\/rheumatology\/ken246","volume":"47","author":"JC Nossent","year":"2008","unstructured":"Nossent JC, Lester S, Zahra D, Mackay CR, Rischmueller M. Polymorphism in the 5\u2032 regulatory region of the B-lymphocyte activating factor gene is associated with the Ro\/La autoantibody response and serum BAFF levels in primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2008;47(9):1311\u20136. https:\/\/doi.org\/10.1093\/rheumatology\/ken246.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"865_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/ar1884","volume":"8","author":"JE Gottenberg","year":"2006","unstructured":"Gottenberg JE, Sellam J, Ittah M, et al. No evidence for an association between the -871 T\/C promoter polymorphism in the B-cell-activating factor gene and primary Sj\u00f6gren\u2019s syndrome. Arthritis Res Ther. 2006;8(1):R30. https:\/\/doi.org\/10.1186\/ar1884.","journal-title":"Arthritis Res Ther"},{"key":"865_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00312","volume":"10","author":"ILA Bodewes","year":"2019","unstructured":"Bodewes ILA, van der Spek PJ, Leon LG,\u00a0et al. Fatigue in Sj\u00f6gren\u2019s syndrome: a search for biomarkers and treatment targets. Front Immunol. 2019;10:312. https:\/\/doi.org\/10.3389\/fimmu.2019.00312.","journal-title":"Front Immunol"},{"key":"865_CR30","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1126\/science.1084909","volume":"300","author":"C Hu","year":"2003","unstructured":"Hu C, Ahmed M, Melia TJ, S\u00f6llner TH, Mayer T, Rothman JE. Fusion of cells by flipped SNAREs. Science. 2003;300:1745\u20139. https:\/\/doi.org\/10.1126\/science.1084909.","journal-title":"Science"},{"key":"865_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-15-191","volume":"15","author":"A Balkarli","year":"2014","unstructured":"Balkarli A, Seng\u00fcl C, Tepeli E, Balkarli H, Cobankara V. Synaptosomal associated protein 25 (Snap-25) gene polymorphism frequency in fibromyalgia syndrome and relationship with clinical symptoms. BMC Musculoskelet Disord. 2014;15:191. https:\/\/doi.org\/10.1186\/1471-2474-15-191.","journal-title":"BMC Musculoskelet Disord"},{"key":"865_CR32","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.biopsych.2004.11.024","volume":"57","author":"SV Faraone","year":"2005","unstructured":"Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit\/hyperactivity disorder. Biol Psychiatry. 2005;57:1313\u201323. https:\/\/doi.org\/10.1016\/j.biopsych.2004.11.024.","journal-title":"Biol Psychiatry"},{"key":"865_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1749-6632.2008.03995.x","volume":"1152","author":"I Corradini","year":"2009","unstructured":"Corradini I, Verderio C, Sala M, Wilson MC, Matteoli M. SNAP-25 in neuropsychiatric disorders. Ann N Y Acad Sci. 2009;1152:93\u20139. https:\/\/doi.org\/10.1111\/j.1749-6632.2008.03995.x.","journal-title":"Ann N Y Acad Sci"},{"key":"865_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-9-53","volume":"9","author":"A Brinkmalm","year":"2014","unstructured":"Brinkmalm A, Brinkmalm G, Honer WG, et al. SNAP-25 is a promising novel cerebrospinal fluid biomarker for synapse degeneration in Alzheimer\u2019s disease. Mol Neurodegener. 2014;9:53. https:\/\/doi.org\/10.1186\/1750-1326-9-53.","journal-title":"Mol Neurodegener"},{"key":"865_CR35","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1002\/art.23936","volume":"58","author":"K Lundberg","year":"2008","unstructured":"Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated \u03b1-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008;58:3009\u201319. https:\/\/doi.org\/10.1002\/art.23936.","journal-title":"Arthritis Rheum"},{"key":"865_CR36","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/870214","volume":"2011","author":"A Pontillo","year":"2011","unstructured":"Pontillo A, Di Toro N, Edomi P, et al. Anti\u2013enolase antibodies in serum from pediatric patients affected by inflammatory diseases: diagnostic and pathogenetic insights. Int J Rheumatol. 2011;2011:6. https:\/\/doi.org\/10.1155\/2011\/870214.","journal-title":"Int J Rheumatol"},{"key":"865_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jneuroim.2007.01.018","volume":"185","author":"M Yoneda","year":"2007","unstructured":"Yoneda M, Fujii A, Ito A, Yokoyama H, Nakagawa H, Kuriyama M. High prevalence of serum autoantibodies against the amino terminal of \u03b1enolase in Hashimoto\u2019s encephalopathy. J Neuroimmunol. 2007;185:195\u2013200. https:\/\/doi.org\/10.1016\/j.jneuroim.2007.01.018.","journal-title":"J Neuroimmunol"},{"key":"865_CR38","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1002\/art.11074","volume":"48","author":"KH Lee","year":"2003","unstructured":"Lee KH, Chung H-S, Kim HS, et al. Human \u03b1-enolase from endothelial cells as a target antigen of anti\u2013endothelial cell antibody in Beh\u00e7et\u2019s disease. Arthritis Rheum. 2003;48:2025\u201335. https:\/\/doi.org\/10.1002\/art.11074.","journal-title":"Arthritis Rheum"},{"key":"865_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-11-31","volume":"11","author":"EB Gilliam","year":"2013","unstructured":"Gilliam EB, Chauhan A, Moore T. Evaluation of anti-citrullinated type II collagen and anti-citrullinated vimentin antibodies in patients with juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2013;11:31. https:\/\/doi.org\/10.1186\/1546-0096-11-31.","journal-title":"Pediatr Rheumatol Online J"},{"key":"865_CR40","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.clim.2017.09.012","volume":"183","author":"A Nezos","year":"2017","unstructured":"Nezos A, Cinoku I, Mavragani CP, Moutsopoulos HM. Antibodies against citrullinated alpha enolase peptides in primary Sjogren\u2019s syndrome. Clin Immunol. 2017;183:300\u20133. https:\/\/doi.org\/10.1016\/j.clim.2017.09.012.","journal-title":"Clin Immunol"},{"key":"865_CR41","doi-asserted-by":"publisher","first-page":"876","DOI":"10.3109\/14397595.2015.1034941","volume":"25","author":"N Azuma","year":"2015","unstructured":"Azuma N, Katada Y, Kitano S, et al. Rapid decrease in salivary epidermal growth factor levels in patients with Sj\u00f6gren\u2019s syndrome: a 3-year follow-up study. Mod Rheumatol. 2015;25:876\u201382. https:\/\/doi.org\/10.3109\/14397595.2015.1034941.","journal-title":"Mod Rheumatol"},{"key":"865_CR42","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3109\/14397595.2013.850766","volume":"24","author":"N Azuma","year":"2014","unstructured":"Azuma N, Katada Y, Kitano S, et al. Correlation between salivary epidermal growth factor levels and refractory intraoral manifestations in patients with Sj\u00f6gren\u2019s syndrome. Mod Rheumatol. 2014;24:626\u201332. https:\/\/doi.org\/10.3109\/14397595.2013.850766.","journal-title":"Mod Rheumatol"},{"key":"865_CR43","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1037\/neu0000470","volume":"32","author":"P Greenwood","year":"2018","unstructured":"Greenwood P, Schmidt K, Lipsky R, Parasuraman R, Jankord R. A functional promoter variant of the human formimidoyltransferase cyclodeaminase (FTCD) gene is associated with working memory performance in young but not older adults. Neuropsychology. 2018;32:973\u201384. https:\/\/doi.org\/10.1037\/neu0000470.","journal-title":"Neuropsychology"},{"key":"865_CR44","doi-asserted-by":"publisher","DOI":"10.1177\/2050312119850390","volume":"7","author":"E Larssen","year":"2019","unstructured":"Larssen E, Brede C, Hjelle A, et al. Fatigue in Primary Sj\u00f6gren\u2019s Syndrome: a proteomic pilot study of cerebrospinal fluid. SAGE Open Med. 2019;7:2050312119850390. https:\/\/doi.org\/10.1177\/2050312119850390.","journal-title":"SAGE Open Med"},{"key":"865_CR45","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1471-2377-5-22","volume":"5","author":"JN Baraniuk","year":"2005","unstructured":"Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess S S. A chronic fatigue syndrome-related proteome in human cerebrospinal fluid. BMC Neurol. 2005;5:22.","journal-title":"BMC Neurol"},{"key":"865_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.185","volume":"5","author":"MA Frye","year":"2015","unstructured":"Frye MA, Nassan M, Jenkins GD, et al. Feasibility of investigating differential proteomic expression in depression: implications for biomarker development in mood disorders. Transl Psychiatry. 2015;5:e689.","journal-title":"Transl Psychiatry"},{"issue":"6","key":"865_CR47","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2310\/JIM.0b013e31822467cd","volume":"59","author":"VK Ota","year":"2011","unstructured":"Ota VK, Chen ES, Ejchel TF, et al. APOA4 polymorphism as a risk factor for unfavorable lipid serum profile and depression: a cross-sectional study. J Investig Med. 2011;59(6):966\u201370.","journal-title":"J Investig Med"},{"key":"865_CR48","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fneur.2016.00085","volume":"7","author":"VA Nguyen","year":"2016","unstructured":"Nguyen VA, Carey LM, Giummarra L, et al. A pathway proteomic profile of ischemic stroke survivors reveals innate immune dysfunction in association with mild symptoms of depression\u2014a pilot study. Front Neurol. 2016;7:85.","journal-title":"Front Neurol"},{"issue":"4","key":"865_CR49","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/npp.2011.285","volume":"37","author":"C Ditzen","year":"2012","unstructured":"Ditzen C, Tang N, Jastorff AM, et al. Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology. Neuropsychopharmacology. 2012;37(4):1013\u201325.","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"865_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neures.2011.09.003","volume":"72","author":"A Sanchez","year":"2012","unstructured":"Sanchez A, Tripathy D, Yin X, Luo J, Martinez J, Grammas P.\u00a0Pigment epitheliumderived factor (PEDF) protects cortical neurons in vitro from oxidant injury by activation of extracellular signal-regulated kinase (ERK) 1\/2 and induction of Bcl-2. Neurosci Res. 2012;72(1):1\u20138.","journal-title":"Neurosci Res"},{"issue":"1\u20132","key":"865_CR51","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jad.2011.04.021","volume":"133","author":"JR Teyssier","year":"2011","unstructured":"Teyssier JR, Ragot S, Chauvet-G\u00e9linier JC, Trojak B, Bonin B.\u00a0Activation of a DeltaFOSB dependent gene expression pattern in the dorsolateral prefrontal cortex of patients with major depressive disorder. J Affect Disord. 2011;133(1\u20132):174\u20138.","journal-title":"J Affect Disord"},{"issue":"9","key":"865_CR52","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1167\/iovs.05-1267","volume":"47","author":"P Zamiri","year":"2006","unstructured":"Zamiri P, Masli S, Streilein JW, Taylor AW.\u00a0Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest Ophthalmol Vis Sci. 2006;47(9):3912\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"865_CR53","doi-asserted-by":"publisher","first-page":"330","DOI":"10.7150\/ijms.14341","volume":"13","author":"WM Phang","year":"2016","unstructured":"Phang WM, Tan AA, Gopinath SC, Hashim OH, Kiew LV, Chen Y.\u00a0Secretion of N- and O-linked glycoproteins from 4T1 murine mammary carcinoma cells. Int J Med Sci. 2016;13(5):330\u20139.","journal-title":"Int J Med Sci"},{"issue":"13","key":"865_CR54","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1001\/jama.2011.381","volume":"305","author":"EM Schrijvers","year":"2011","unstructured":"Schrijvers EM, Koudstaal PJ, Hofman A, Breteler MM.\u00a0Plasma clusterin and the risk of Alzheimer disease. JAMA. 2011;305(13):1322\u20136.","journal-title":"JAMA"},{"key":"865_CR55","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.1062960","volume":"294","author":"D Chabas","year":"2001","unstructured":"Chabas D, Baranzini SE, Mitchell D, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 2001;294:1731\u20135.","journal-title":"Science"},{"issue":"1","key":"865_CR56","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/mnfr.201300543","volume":"58","author":"E Ansong","year":"2014","unstructured":"Ansong E, Yang W, Diamond AM. Molecular cross-talk between members of distinct families of selenium containing proteins. Mol Nutr Food Res. 2014;58(1):117\u201323.","journal-title":"Mol Nutr Food Res"},{"issue":"7","key":"865_CR57","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1093\/rheumatology\/keq043","volume":"49","author":"D Van Hoogmoed","year":"2010","unstructured":"van Hoogmoed D, Fransen J, Bleijenberg G, van Riel P. Physical and psychosocial correlates of severe fatigue in rheumatoid arthritis. Rheumatology. 2010;49(7):1294\u2013302.","journal-title":"Rheumatology"},{"key":"865_CR58","first-page":"892","volume":"25","author":"B Wang","year":"1998","unstructured":"Wang B, Gladman DD, Urowitz MB. Fatigue in lupus is not correlated with disease activity. J Rheumatol. 1998;25:892\u20135.","journal-title":"J Rheumatol"},{"key":"865_CR59","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/1753425916633236","volume":"22","author":"K B\u00e5rdsen","year":"2016","unstructured":"B\u00e5rdsen K, Nilsen MM, Kval\u00f8y JT, Norheim KB, Jonsson G, Omdal R.\u00a0Heat shock proteins and chronic fatigue in primary Sj\u00f6gren\u2019s syndrome. Innate Immun. 2016;22:162\u20137.","journal-title":"Innate Immun"},{"key":"865_CR60","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.exger.2018.11.003","volume":"115","author":"CA Cabelka","year":"2019","unstructured":"Cabelka CA, Baumann CW, Collins BC, et al. Effects of ovarian hormones and estrogen receptor \u03b1 on physical activity and skeletal muscle fatigue in female mice. Exp Gerontol. 2019;115:155\u201364.","journal-title":"Exp Gerontol"},{"issue":"Suppl 126","key":"865_CR61","first-page":"216","volume":"38","author":"A Machowicz","year":"2020","unstructured":"Machowicz A, Hall I, de Pablo P, et al. Mediterranean diet and risk of Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2020;38(Suppl 126):216\u201321.","journal-title":"Clin Exp Rheumatol"},{"key":"865_CR62","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s13760-020-01341-2","volume":"121","author":"T Kahraman","year":"2021","unstructured":"Kahraman T, Ozdogar AT, Abasiyanik Z, Ozakbas S; Multiple Sclerosis Research Group.\u00a0Associations between smoking and walking, fatigue, depression, and health-related quality of life in persons with multiple sclerosis. Acta Neurol Belg. 2021;121:1199\u2013206.","journal-title":"Acta Neurol Belg"},{"key":"865_CR63","doi-asserted-by":"publisher","first-page":"12286","DOI":"10.1038\/s41598-021-91510-x","volume":"11","author":"MZ Darabseh","year":"2021","unstructured":"Darabseh MZ, Maden-Wilkinson TM, Welbourne G, et al. Fourteen days of smoking cessation improves muscle fatigue resistance and reverses markers of systemic inflammation. Sci Rep. 2021;11:12286.","journal-title":"Sci Rep"},{"key":"865_CR64","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.brat.2018.11.011","volume":"115","author":"BW Heckman","year":"2019","unstructured":"Heckman BW, Cummings KM, Stoltman JJK, et al. Longer duration of smoking abstinence is associated with waning cessation fatigue. Behav Res Ther. 2019;115:12\u20138.","journal-title":"Behav Res Ther"},{"key":"865_CR65","doi-asserted-by":"publisher","first-page":"1916278","DOI":"10.1080\/19490976.2021.1916278","volume":"13","author":"B Caslin","year":"2021","unstructured":"Caslin B, Mohler K, Thiagarajan S, Melamed E.\u00a0Alcohol as friend or foe in autoimmune diseases: a role for gut microbiome? Gut Microbes. 2021;13:1916278.","journal-title":"Gut Microbes"},{"key":"865_CR66","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1093\/ije\/dyy217","volume":"47","author":"A Watad","year":"2018","unstructured":"Watad A, Rosenberg V, Tiosano S, et al. Silicone breast implants and the risk of autoimmune\/rheumatic disorders: a real-world analysis. Int J Epidemiol. 2018;47:1846\u201354. https:\/\/doi.org\/10.1093\/ije\/dyy217.","journal-title":"Int J Epidemiol"},{"key":"865_CR67","doi-asserted-by":"publisher","first-page":"31790","DOI":"10.1038\/srep31790","volume":"6","author":"PC Lopes","year":"2016","unstructured":"Lopes PC, Block P, K\u00f6nig B. Infection- induced behavioural changes reduce connectivity and the potential for disease spread in wild mice contact networks. Sci Rep. 2016;6:31790.","journal-title":"Sci Rep"},{"key":"865_CR68","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0149-7634(88)80004-6","volume":"12","author":"BL Hart","year":"1988","unstructured":"Hart BL. Biological basis of the behavior of sick animals. Neurosci Biobehav Rev. 1988;12:123\u201337.","journal-title":"Neurosci Biobehav Rev"},{"issue":"8","key":"865_CR69","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bbi.2009.06.151","volume":"23","author":"E Harboe","year":"2009","unstructured":"Harboe E, Tjensvoll AB, Vefring HK, G\u00f8ransson LG, Kval\u00f8y JT, Omdal R.\u00a0Fatigue in primary Sj\u00f6gren\u2019s syndrome\u2014a link to sickness behaviour in animals? Brain Behav Immun. 2009;23(8):1104\u20138. https:\/\/doi.org\/10.1016\/j.bbi.2009.06.151.","journal-title":"Brain Behav Immun"},{"key":"865_CR70","doi-asserted-by":"publisher","first-page":"1272833","DOI":"10.1073\/pnas.1118748109","volume":"109","author":"J Lampa","year":"2012","unstructured":"Lampa J, Westman M, Kadetoff D, et al. Peripheral inflammatory disease associated with centrally activated IL-1 system in humans and mice. Proc Natl Acad Sci USA. 2012;109:1272833.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"865_CR71","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00296-004-0463-z","volume":"25","author":"R Omdal","year":"2005","unstructured":"Omdal R, Gunnarsson R. The effect of interleukin-1 blockade on fatigue in rheumatoid arthritis\u2014a pilot study. Rheumatol Int. 2005;25(6):481\u20134.","journal-title":"Rheumatol Int"},{"issue":"10","key":"865_CR72","doi-asserted-by":"publisher","DOI":"10.2337\/dc11-1196","volume":"34","author":"C Cavelti-Weder","year":"2011","unstructured":"Cavelti-Weder C, Furrer R, Keller C, et al. Inhibition of IL1beta improves fatigue in type 2 diabetes. Diabetes Care. 2011;34(10):e158.","journal-title":"Diabetes Care"},{"issue":"1","key":"865_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030123","volume":"7","author":"KB Norheim","year":"2012","unstructured":"Norheim KB, Harboe E, G\u00f8ransson LG, Omdal R.\u00a0Interleukin-1 inhibition and fatigue in primary Sj\u00f6gren\u2019s syndrome\u2014a double blind, randomised clinical trial. PLoS ONE. 2012;7(1):e30123. https:\/\/doi.org\/10.1371\/journal.pone.0030123.","journal-title":"PLoS ONE"},{"key":"865_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-019-1502-8","volume":"16","author":"K B\u00e5RDSEN","year":"2019","unstructured":"B\u00e5RDSEN K, Brede C, Kvivik I, et al. Interleukin-1-related activity and hypocretin-1 in cerebrospinal fluid contribute to fatigue in primary Sj\u00f6gren\u2019s syndrome. J Neuroinflammation. 2019;16:102.","journal-title":"J Neuroinflammation"},{"issue":"2","key":"865_CR75","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000282","volume":"2","author":"N Howard Tripp","year":"2016","unstructured":"Howard Tripp N, Tarn J, Natasari A, et al. Fatigue in primary Sj\u00f6gren\u2019s syndrome is associated with lower levels of proinflammatory cytokines. RMD Open. 2016;2(2):e000282. https:\/\/doi.org\/10.1136\/rmdopen-2016-000282.","journal-title":"RMD Open"},{"issue":"11","key":"865_CR76","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1007\/s00296-019-04354-0","volume":"39","author":"K Davies","year":"2019","unstructured":"Davies K, Mirza K, Tarn J, et al. Fatigue in primary Sj\u00f6gren\u2019s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study. Rheumatol Int. 2019;39(11):1867\u201373. https:\/\/doi.org\/10.1007\/s00296-019-04354-0.","journal-title":"Rheumatol Int"},{"key":"865_CR77","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1741-7015-11-93","volume":"11","author":"A Tincani","year":"2013","unstructured":"Tincani A, Andreoli L, Cavazzana I, et al. Novel aspects of Sj\u00f6gren\u2019s syndrome in 2012. BMC Med. 2013;11:93.","journal-title":"BMC Med"},{"key":"865_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112860","volume":"209","author":"J Li","year":"2025","unstructured":"Li J, Chen T. Epstein-Barr virus and the origin of frailty and fatigue: a two-sample multivariable bidirectional Mendelian randomization study. Exp Gerontol. 2025;209:112860.","journal-title":"Exp Gerontol"},{"key":"865_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11030666","author":"F Baroun","year":"2023","unstructured":"Baroun F, Albasri A, Abutiban F, Alhajeri H.\u00a0CVAPPS: a cross-sectional study of SARS-CoV-2 vaccine acceptance, perceptions, and post-vaccination side effects among rheumatic disease patients in Kuwait. Vaccines (Basel). 2023. https:\/\/doi.org\/10.3390\/vaccines11030666.","journal-title":"Vaccines (Basel)"},{"key":"865_CR80","doi-asserted-by":"publisher","first-page":"123","DOI":"10.31138\/mjr.140223.sof","volume":"35","author":"AA Younis","year":"2024","unstructured":"Younis AA, Ridha AA, Humadi YA, et al. Safety of COVID-19 vaccine in patients with rheumatic and musculoskeletal diseases. Mediterr J Rheumatol. 2024;35:123\u201333.","journal-title":"Mediterr J Rheumatol"},{"key":"865_CR81","doi-asserted-by":"publisher","first-page":"3838","DOI":"10.1093\/rheumatology\/kead144","volume":"62","author":"K Jagtap","year":"2023","unstructured":"Jagtap K, Naveen R, Day J, et al. Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys. Rheumatology (Oxford). 2023;62:3838\u201348.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR82","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/apa.16652","volume":"112","author":"B Sahn","year":"2023","unstructured":"Sahn B, Lu Y, Hui-Yuen JS, et al. The safety of COVID-19 vaccination in immunocompromised children and young adults with immune-mediated inflammatory disease. Acta Paediatr. 2023;112:794\u2013801.","journal-title":"Acta Paediatr"},{"key":"865_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004511","volume":"22","author":"RS Peter","year":"2025","unstructured":"Peter RS, Nieters A, G\u00f6PEL S, et al. Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19\/post-COVID-19 syndrome in the second year after acute infection: a population-based, nested case-control study. PLoS Med. 2025;22:e1004511.","journal-title":"PLoS Med"},{"key":"865_CR84","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/annrheumdis-2014-206418","volume":"75","author":"P Brito-Zeron","year":"2016","unstructured":"Brito-Zeron P, Kostov B, Solans R, et al. Systemic activity and mortality in primary Sjogren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients. Ann Rheum Dis. 2016;75:348\u201355.","journal-title":"Ann Rheum Dis"},{"key":"865_CR85","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","volume":"79","author":"V Furer","year":"2020","unstructured":"Furer V, Rondaan C, Heijstek MW, et al. 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2020;79:39\u201352.","journal-title":"Ann Rheum Dis"},{"key":"865_CR86","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/rheumatology\/32.12.1072","volume":"32","author":"B Gudbjornsson","year":"1993","unstructured":"Gudbjornsson B, Broman JE, Hetta J, Hallgren R. Sleep disturbances in patients with primary Sj\u00f6gren\u2019s syndrome. Br J Rheumatol. 1993;32:1072\u20136.","journal-title":"Br J Rheumatol"},{"key":"865_CR87","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.smrv.2007.07.007","volume":"12","author":"P Meerlo","year":"2008","unstructured":"Meerlo P, Sgoifo A, Suchecki D. Restricted and disrupted sleep: effects on autonomic function, neuroendocrine stress systems and stress responsivity. Sleep Med Rev. 2008;12:197\u2013210.","journal-title":"Sleep Med Rev"},{"issue":"Suppl. 118","key":"865_CR88","first-page":"78","volume":"37","author":"I Lewis","year":"2019","unstructured":"Lewis I, Hackett KL, Ng W-F, Ellis J, Newton JL. A two- phase cohort study of the sleep phenotype within primary Sj\u00f6gren\u2019s syndrome and its clinical correlates. Clin Exp Rheumatol. 2019;37(Suppl. 118):78\u201382.","journal-title":"Clin Exp Rheumatol"},{"key":"865_CR89","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/s41577-019-0190-z","volume":"19","author":"MR Irwin","year":"2019","unstructured":"Irwin MR. Sleep and inflammation: partners in sickness and in health. Nat Rev Immunol. 2019;19:702\u201315.","journal-title":"Nat Rev Immunol"},{"key":"865_CR90","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1210\/jc.2013-4254","volume":"99","author":"A Guyon","year":"2014","unstructured":"Guyon A, Balbo M, Morselli LL,\u00a0et al. Adverse effects of two nights of sleep restriction on the hypothalamic\u2013pituitary\u2013adrenal axis in healthy men. J Clin Endocrinol Metab. 2014;99:2861\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"865_CR91","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/rheumatology\/kex062.311","volume":"56","author":"KL Hackett","year":"2017","unstructured":"Hackett KL, Gotts ZM, Ellis J,\u00a0et al. An investigation into the prevalence of sleep disturbances in primary Sj\u00f6gren\u2019s syndrome: a systematic review of the literature. Rheumatology (Oxford). 2017;56:570\u201380.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR92","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/acr.22720","volume":"68","author":"T Karageorgas","year":"2016","unstructured":"Karageorgas T, Fragioudaki S, Nezos A, Karaiskos D, Moutsopoulos HM, Mavragani CP.\u00a0Fatigue in primary Sj\u00f6gren\u2019s syndrome: clinical, laboratory, psychometric, and biologic associations. Arthritis Care Res (Hoboken). 2016;68:123\u201331.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"865_CR93","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","volume":"34","author":"S Haliloglu","year":"2014","unstructured":"Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A. Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Int. 2014;34:1275\u201380.","journal-title":"Rheumatol Int"},{"issue":"Suppl. 74","key":"865_CR94","first-page":"S117","volume":"30","author":"C Iannuccelli","year":"2012","unstructured":"Iannuccelli C, Spinelli FR, Guzzo MP, et al. Fatigue and widespread pain in systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome: symptoms of the inflammatory disease or associated fibromyalgia? Clin Exp Rheumatol. 2012;30(Suppl. 74):S117\u201321.","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl. 96","key":"865_CR95","first-page":"S9","volume":"34","author":"BY Choi","year":"2016","unstructured":"Choi BY, Oh HJ, Lee YJ, Song YW. Prevalence and clinical impact of fibromyalgia in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2016;34(Suppl. 96):S9-13.","journal-title":"Clin Exp Rheumatol"},{"key":"865_CR96","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.3899\/jrheum.090942","volume":"37","author":"JH Kang","year":"2010","unstructured":"Kang JH, Lin HC. Comorbidities in patients with primary Sj\u00f6gren\u2019s syndrome: a registrybased case-control study. J Rheumatol. 2010;37:1188\u201394.","journal-title":"J Rheumatol"},{"issue":"Suppl 105","key":"865_CR97","first-page":"28","volume":"35","author":"V Torrente-Segarra","year":"2017","unstructured":"Torrente-Segarra V, Corominas H, S\u00e1nchez-Piedra C, et al. Fibromyalgia prevalence and associated factors in primary Sj\u00f6gren\u2019s syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJ\u00d6GRENSER). Clin Exp Rheumatol. 2017;35(Suppl 105):28\u201334.","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 133","key":"865_CR98","doi-asserted-by":"publisher","first-page":"140","DOI":"10.55563\/clinexprheumatol\/uxlsh3","volume":"39","author":"JJ Dubost","year":"2021","unstructured":"Dubost JJ, Couderc M, Pereira B, et al. Concomitant fibromyalgia in primary Sj\u00f6gren\u2019s syndrome in the French ASSESS cohort: comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician\u2019s opinion. Clin Exp Rheumatol. 2021;39(Suppl 133):140\u20135.","journal-title":"Clin Exp Rheumatol"},{"key":"865_CR99","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1136\/ard.57.5.291","volume":"57","author":"PJ Barendregt","year":"1998","unstructured":"Barendregt PJ, Visser MR, Smets EM, et al. Fatigue in primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 1998;57:291\u20135.","journal-title":"Ann Rheum Dis"},{"key":"865_CR100","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/BF02208084","volume":"14","author":"L Jacobsson","year":"1995","unstructured":"Jacobsson L, Kirtava Z, Olsson G, Axell T, Manthorpe R. Tiredness in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 1995;14:51\u20135.","journal-title":"Clin Rheumatol"},{"key":"865_CR101","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/art.24311","volume":"59","author":"B Segal","year":"2008","unstructured":"Segal B, Thomas W, Rogers T, et al. Prevalence, severity, and predictors of fatigue in subjects with primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheum. 2008;59:1780\u20137.","journal-title":"Arthritis Rheum"},{"key":"865_CR102","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1093\/rheumatology\/kev254","volume":"54","author":"J Duran","year":"2015","unstructured":"Duran J, Combe B, Niu J, Rincheval N, Gaujoux-Viala C, Felson DT. The effect on treatment response of fibromyalgic symptoms in early rheumatoid arthritis patients: results from the ESPOIR cohort. Rheumatology (Oxford). 2015;54:2166\u201370.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR103","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/annrheumdis-2017-212378","volume":"7","author":"A Molt\u00f3","year":"2018","unstructured":"Molt\u00f3 A, Etcheto A, Gossec L, et al. Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers\u2019 effectiveness in axial spondyloarthritis: results of a prospective, multicentre study. Ann Rheum Dis. 2018;7:533\u201340.","journal-title":"Ann Rheum Dis"},{"key":"865_CR104","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3109\/03009748909095399","volume":"18","author":"C Vitali","year":"1989","unstructured":"Vitali C, Tavoni A, Neri R, Castrogiovanni P, Pasero G, Bombardieri S. Fibromyalgia features in patients with Sj\u00f6gren\u2019s syndrome\u2014evidence of a relationship with psychological depression. Scand J Rheumatol. 1989;18:21\u20137.","journal-title":"Scand J Rheumatol"},{"key":"865_CR105","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.640618","volume":"12","author":"SY Gau","year":"2021","unstructured":"Gau SY, Leong PY, Lin CL, Tsou HK, Wei JC. Higher risk for Sj\u00f6gren\u2019s syndrome in patients with fibromyalgia: a nationwide population-based cohort study. Front Immunol. 2021;12:640618. https:\/\/doi.org\/10.3389\/fimmu.2021.640618.","journal-title":"Front Immunol"},{"issue":"5","key":"865_CR106","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1093\/rheumatology\/key329","volume":"60","author":"JM Pego-Reigosa","year":"2021","unstructured":"Pego-Reigosa JM, Restrepo V\u00e9lez J, Baldini C, R\u00faa-Figueroa Fern\u00e1ndez de Larrinoa \u00cd. Comorbidities (excluding lymphoma) in Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2021;60(5):2075\u201384. https:\/\/doi.org\/10.1093\/rheumatology\/key329.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"865_CR107","doi-asserted-by":"publisher","first-page":"e216","DOI":"10.1016\/S2665-9913(23)00340-5","volume":"6","author":"Y Nguyen","year":"2024","unstructured":"Nguyen Y, Nocturne G, Henry J, et al. Identification of distinct subgroups of Sj\u00f6gren\u2019s disease by cluster analysis based on clinical and biological manifestations: data from the cross-sectional Paris-Saclay and the prospective ASSESS cohorts. Lancet Rheumatol. 2024;6(4):e216\u201325. https:\/\/doi.org\/10.1016\/S2665-9913(23)00340-5.","journal-title":"Lancet Rheumatol"},{"key":"865_CR108","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1007\/s00296-021-04916-1","volume":"42","author":"G Vera Cruz","year":"2022","unstructured":"Vera Cruz G, Bucourt E, Reveillere C, et al. Machine learning reveals the most important psychological and social variables predicting the differential diagnosis of rheumatic and musculoskeletal diseases. Rheumatol Int. 2022;42:1053\u201362.","journal-title":"Rheumatol Int"},{"key":"865_CR109","first-page":"730","volume":"2012","author":"K Malin","year":"2012","unstructured":"Malin K, Littlejohn GO. Neuroticism in young women with fibromyalgia links to key clinical features. Pain Res Treat. 2012;2012:730\u201341.","journal-title":"Pain Res Treat"},{"issue":"4","key":"865_CR110","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1007\/s10880-011-9263-2","volume":"18","author":"MP Martinez","year":"2011","unstructured":"Martinez MP, Sanchez AI, Miro E, Medina A, Lami MJ. The relationship between the fear-avoidance model of pain and personality traits in fibromyalgia patients. J Clin Psychol Med Settings. 2011;18(4):380\u201391. https:\/\/doi.org\/10.1007\/s10880-011-9263-2.","journal-title":"J Clin Psychol Med Settings"},{"key":"865_CR111","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.mp.4002055","volume":"13","author":"I Goshen","year":"2008","unstructured":"Goshen I, Kreisel T, Ben-Menachem-Zidon O, et al. Brain interleukin-1 mediates chronic stress-induced depression in mice via adrenocortical activation and hippocampal neurogenesis suppression. Mol Psychiatry. 2008;13:717\u201328.","journal-title":"Mol Psychiatry"},{"key":"865_CR112","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1556\/650.2021.32234","volume":"162","author":"L V M\u00f3dis","year":"2021","unstructured":"V M\u00f3dis L, Sz\u00e1nt\u00f3 A, Bug\u00e1n A. A primer Sj\u00f6gren-szindr\u00f3ma pszichol\u00f3giai vonatkoz\u00e1sai [Psychological features of primary Sj\u00f6gren syndrome]. Orv Hetil. 2021;162(39):1558-1566.","journal-title":"Orv Hetil"},{"key":"865_CR113","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1080\/13548500123876","volume":"6","author":"SI Andersson","year":"2001","unstructured":"Andersson SI, Manthorpe R, Theander E. Situational patterns in coping with primary Sj\u00f6gren\u2019s syndrome. Psychol Health Med. 2001;6:29\u201340.","journal-title":"Psychol Health Med"},{"key":"865_CR114","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.autrev.2015.12.005","volume":"15","author":"B Porcelli","year":"2016","unstructured":"Porcelli B, Pozza A, Bizzaro N, et al. Association between stressful life events and autoimmune diseases: a systematic review and meta-analysis of retrospective case-control studies. Autoimmun Rev. 2016;15:325\u201334.","journal-title":"Autoimmun Rev"},{"key":"865_CR115","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1136\/ard.2007.084152","volume":"68","author":"D Karaiskos","year":"2009","unstructured":"Karaiskos D, Mavragani CP, Makaroni S, et al. Stress, coping strategies and social support in patients with primary Sj\u00f6gren\u2019s syndrome prior to disease onset: a retrospective case-control study. Ann Rheum Dis. 2009;68:40\u20136.","journal-title":"Ann Rheum Dis"},{"key":"865_CR116","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000885","volume":"5","author":"KL Hackett","year":"2019","unstructured":"Hackett KL, Davies K, Tarn J, et al. Pain and depression are associated with both physical and mental fatigue independently of comorbidities and medications in primary Sj\u00f6gren\u2019s syndrome. RMD Open. 2019;5:e000885.","journal-title":"RMD Open"},{"key":"865_CR117","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/rheumatology\/keq009","volume":"49","author":"WF Ng","year":"2010","unstructured":"Ng WF, Bowman SJ. Primary Sj\u00f6gren\u2019s syndrome: too dry and too tired. Rheumatology (Oxford). 2010;49:844\u201353.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR118","doi-asserted-by":"publisher","first-page":"78","DOI":"10.2478\/rir-2023-0012","volume":"4","author":"T Costa","year":"2023","unstructured":"osta T, Rushton SP, Watson S, Ng WF; UK primary Sj\u00f6gren's Syndrome Registry.\u00a0Depression in Sj\u00f6gren\u2019s syndrome mediates the relationship between pain, fatigue, sleepiness, and overall quality of life. Rheumatol Immunol Res. 2023;4:78\u201389.","journal-title":"Rheumatol Immunol Res"},{"key":"865_CR119","first-page":"2318","volume":"40","author":"RF Prak","year":"2022","unstructured":"Prak RF, Arends S, Verstappen GM, et al. Fatigue in primary Sj\u00f6gren\u2019s syndrome is associated with an objective decline in physical performance, pain and depression. Clin Exp Rheumatol. 2022;40:2318\u201328.","journal-title":"Clin Exp Rheumatol"},{"key":"865_CR120","doi-asserted-by":"publisher","first-page":"375","DOI":"10.46497\/ArchRheumatol.2023.9790","volume":"38","author":"K Ayar","year":"2023","unstructured":"Ayar K, Kasapo\u011flu Aksoy M, Dilara Hattato\u011flu T, Ye\u015fil B.\u00a0Depression is the most significant independent predictor of fatigue in patients with primary Sj\u00f6gren\u2019s syndrome. Arch Rheumatol. 2023;38:375\u201386.","journal-title":"Arch Rheumatol"},{"key":"865_CR121","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1007\/s12325-020-01606-5","volume":"38","author":"DD Mitsikostas","year":"2021","unstructured":"Mitsikostas DD, Doskas T, Gkatzonis S, et al. A prospective, observational, cohort study to assess the efficacy and safety of prolonged-release fampridine in cognition, fatigue, depression, and quality of life in multiple sclerosis patients: the FAMILY study. Adv Ther. 2021;38:1536\u201351.","journal-title":"Adv Ther"},{"key":"865_CR122","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s12888-018-1715-x","volume":"18","author":"Y Cui","year":"2018","unstructured":"Cui Y, Xia L, Li L, Zhao Q, Chen S, Gu Z.\u00a0Anxiety and depression in primary Sj\u00f6gren\u2019s syndrome: a cross-sectional study. BMC Psychiatry. 2018;18:131.","journal-title":"BMC Psychiatry"},{"key":"865_CR123","doi-asserted-by":"publisher","first-page":"1507242","DOI":"10.3389\/fmed.2024.1507242","volume":"11","author":"S Beider","year":"2024","unstructured":"Beider S, Stephan M, Seeliger T, Skripuletz T, Witte T, Ernst D.\u00a0A comparative cross-sectional study of psychological distress, fatigue, and physical activity in patients with rheumatoid arthritis, systemic lupus erythematosus, and Sj\u00f6gren\u2019s disease. Front Med (Lausanne). 2024;11:1507242.","journal-title":"Front Med (Lausanne)."},{"issue":"1","key":"865_CR124","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1037\/0021-843X.87.1.49","volume":"87","author":"LY Abramson","year":"1978","unstructured":"Abramson LY, Seligman ME, Teasdale JD.\u00a0Learned helplessness in humans: critique and reformulation. J Abnorm Psychol. 1978;87(1):49\u201374.","journal-title":"J Abnorm Psychol"},{"key":"865_CR125","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1136\/ard.2011.154245","volume":"71","author":"EJ Wouters","year":"2012","unstructured":"Wouters EJ, van Leeuwen N, Bossema ER, et al. Physical activity and physical activity cognitions are potential factors maintaining fatigue in patients with primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2012;71:668\u201373.","journal-title":"Ann Rheum Dis"},{"key":"865_CR126","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/BF02802730","volume":"16","author":"J Trager","year":"2001","unstructured":"Trager J, Brewster J. The effectiveness of psychological profiles. J Police Crim Psych. 2001;16:20\u20138. https:\/\/doi.org\/10.1007\/BF02802730.","journal-title":"J Police Crim Psych"},{"key":"865_CR127","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/rheumatology\/keu387","volume":"54","author":"N Van Leeuwen","year":"2015","unstructured":"Van Leeuwen N, Bossema ER, Knoop H, et al. Psychological profiles in patients with Sj\u00f6gren\u2019s syndrome related to fatigue: a cluster analysis. Rheumatology (Oxford). 2015;54:776\u201383.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR128","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1017\/S0033291700037429","volume":"25","author":"C Ray","year":"1995","unstructured":"Ray C, Jefferies S, Weir WRC. Coping with Chronic Fatigue Syndrome: illness responses and their relationship with fatigue, functional impairment and emotional status. Psychol Med. 1995;25:937\u201345.","journal-title":"Psychol Med"},{"key":"865_CR129","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1159\/000327582","volume":"80","author":"M Cella","year":"2011","unstructured":"Cella M, Chalder T, White PD. Does the heterogeneity of chronic fatigue syndrome moderate the response to cognitive behaviour therapy? An exploratory study. Psychother Psychosom. 2011;80:353\u20138.","journal-title":"Psychother Psychosom"},{"key":"865_CR130","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1136\/annrheumdis-2012-201381","volume":"72","author":"Z Brkic","year":"2013","unstructured":"Brkic Z, Maria NI, van Helden-Meeuwsen CG, et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren\u2019s syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis. 2013;72:728\u201335.","journal-title":"Ann Rheum Dis"},{"key":"865_CR131","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1093\/rheumatology\/kex490","volume":"57","author":"ILA Bodewes","year":"2018","unstructured":"Bodewes ILA, Al-Ali S, van Helden-Meeuwsen CG, et al. Systemic interferon type I and type II signatures in primary Sjogren\u2019s syndrome reveal differences in biological disease activity. Rheumatology (Oxford). 2018;57:921\u201330.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"865_CR132","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW.\u00a0From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46\u201356. https:\/\/doi.org\/10.1038\/nrn2297.","journal-title":"Nat Rev Neurosci"},{"issue":"2","key":"865_CR133","doi-asserted-by":"publisher","first-page":"e85","DOI":"10.1016\/S2665-9913(19)30042-6","volume":"1","author":"JR Tarn","year":"2019","unstructured":"Tarn JR, Howard-Tripp N, Lendrem DW,\u00a0et al. Symptom-based stratification of patients with primary Sj\u00f6gren\u2019s syndrome: multi-dimensional characterisation of international observational cohorts and reanalyses of randomised clinical trials. Lancet Rheumatol. 2019;1(2):e85\u201394. https:\/\/doi.org\/10.1016\/S2665-9913(19)30042-6.","journal-title":"Lancet Rheumatol."},{"key":"865_CR134","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/rheumatology\/keu361","volume":"54","author":"D Lendrem","year":"2015","unstructured":"Lendrem D, Mitchell S, McMeekin P, et al. Do the EULAR Sj\u00f6gren\u2019s syndrome outcome measures correlate with health status in primary Sj\u00f6gren\u2019s syndrome? Rheumatology. 2015;54:655\u20139.","journal-title":"Rheumatology"},{"key":"865_CR135","doi-asserted-by":"publisher","first-page":"11048","DOI":"10.1016\/j.bbi.2009.06.151","volume":"23","author":"E Harboe","year":"2009","unstructured":"Harboe E, Tjensvoll AB, Vefring HK, G\u00f8ransson LG, Kval\u00f8y JT, Omdal R. Fatigue in primarySj\u00f6gren\u2019s syndromea link to sickness behaviour in animals? Brain Behav Immun. 2009;23:11048.","journal-title":"Brain Behav Immun"},{"key":"865_CR136","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.4067-11.2011","volume":"31","author":"Y Huang","year":"2011","unstructured":"Huang Y, Smith DE, Ibanez-Sandoval O, Sims JE, Friedman WJ. Neuron-specific effects of interleukin-1beta are mediated by a novel isoform of the IL-1 receptor accessory protein. J Neurosci. 2011;31:1804859.","journal-title":"J Neurosci"},{"key":"865_CR137","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pneurobio.2010.05.002","volume":"92","author":"RA Stetler","year":"2010","unstructured":"Stetler RA, Gan Y, Zhang W,\u00a0et al. Heat shock proteins: cellular and molecular mechanisms in the central nervous system. Prog Neurobiol. 2010;92:184\u2013211.","journal-title":"Prog Neurobiol"},{"key":"865_CR138","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/acps.12656","volume":"134","author":"P Ellul","year":"2016","unstructured":"Ellul P, Boyer L, Groc L, Leboyer M, Fond G. Interleukin-1\u03b2-targeted treatment strategies in inflammatory depression: toward personalized care. Acta Psychiatr Scand. 2016;134:469\u201384.","journal-title":"Acta Psychiatr Scand"},{"key":"865_CR139","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.immuni.2020.12.016","volume":"54","author":"AM Klawonn","year":"2021","unstructured":"Klawonn AM, Fritz M, Castany S, et al. Microglial activation elicits a negative affective state through prostaglandin-mediated modulation of striatal neurons. Immunity. 2021;54:225-234.e226.","journal-title":"Immunity"},{"issue":"12","key":"865_CR140","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.jagp.2017.07.012","volume":"25","author":"JM Kim","year":"2017","unstructured":"Kim JM, Kang HJ, Kim JW, et al. Associations of tumor necrosis factor-alpha and interleukin-1beta levels and polymorphisms with post-stroke depression. Am J Geriatr Psychiatry. 2017;25(12):1300\u20138. https:\/\/doi.org\/10.1016\/j.jagp.2017.07.012.","journal-title":"Am J Geriatr Psychiatry"},{"key":"865_CR141","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.coph.2012.02.009","volume":"12","author":"JE Towne","year":"2012","unstructured":"Towne JE, Sims JE. IL-36 in psoriasis. Curr Opin Pharmacol. 2012;12:486\u201390.","journal-title":"Curr Opin Pharmacol"},{"key":"865_CR142","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1136\/annrheumdis-2012-202264","volume":"72","author":"S Frey","year":"2013","unstructured":"Frey S, Derer A, Messbacher ME, et al. The novel cytokine interleukin-36\u03b1 is expressed in Psoriatic and Rheumatoid Arthritis synoviumpsoriatic arthritis. Ann Rheum Dis. 2013;72:1569\u201374.","journal-title":"Ann Rheum Dis"},{"key":"865_CR143","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1097\/MIB.0000000000000198","volume":"20","author":"M Friedrich","year":"2014","unstructured":"Friedrich M, Tillack C, Wollenberg A, Schauber J, Brand S. IL-36 gamma sustains a proinflammatory self-amplifying loop with IL-17c in anti-TNF-induced psoriasiform skin lesions of patients with Crohn\u2019s disease. Inflamm Bowel Dis. 2014;20:1891\u2013901.","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"865_CR144","doi-asserted-by":"publisher","DOI":"10.3390\/biom11020251","volume":"11","author":"N Del Papa","year":"2021","unstructured":"Del Papa N, Minniti A, Lorini M, et al. The role of interferons in the pathogenesis of Sj\u00f6gren\u2019s Syndrome and future therapeutic perspectives. Biomolecules. 2021;11(2):251. https:\/\/doi.org\/10.3390\/biom11020251.","journal-title":"Biomolecules"},{"key":"865_CR145","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.4049\/jimmunol.0903670","volume":"185","author":"JD Mezrich","year":"2010","unstructured":"Mezrich JD, Fechner JH, Zhang X, Johnson BP, Burlingham WJ, Bradfield CA. An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells. J Immunol. 2010;185:3190\u20138. https:\/\/doi.org\/10.4049\/jimmunol.0903670.","journal-title":"J Immunol"},{"issue":"12","key":"865_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19123953","volume":"19","author":"FR de Oliveira","year":"2018","unstructured":"de Oliveira FR, Fantucci MZ, Adriano L, et al. Neurological and inflammatory manifestations in Sj\u00f6gren\u2019s Syndrome: the role of the Kynurenine Metabolic Pathway. Int J Mol Sci. 2018;19(12):3953. https:\/\/doi.org\/10.3390\/ijms19123953.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"865_CR147","first-page":"27","volume":"38 Suppl 126","author":"WM Sardenberg","year":"2020","unstructured":"Sardenberg WM, Santos MCLFS, Skarstein K, et al. Acinar adipose tissue infiltration in salivary gland biopsy is associated with kynurenines-interferon-gamma pathway inflammation biomarkers. Clin Exp Rheumatol. 2020;38 Suppl 126(4):27\u201333.","journal-title":"Clin Exp Rheumatol"},{"key":"865_CR148","first-page":"2363","volume":"41","author":"Y Park","year":"2023","unstructured":"Park Y, Lee JJ, Koh JH, Kim MJ, Park SH, Kwok SK.\u00a0Kynurenine pathway can be a potential biomarker of fatigue in primary Sj\u00f6gren\u2019s syndrome. Clin Exp Rheumatol. 2023;41:2363\u201370.","journal-title":"Clin Exp Rheumatol"},{"issue":"20","key":"865_CR149","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S1462399406000068","volume":"8","author":"JP Ruddick","year":"2006","unstructured":"Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA.\u00a0Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med. 2006;8(20):1\u201327. https:\/\/doi.org\/10.1017\/S1462399406000068.","journal-title":"Expert Rev Mol Med"},{"key":"865_CR150","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.tins.2013.10.003","volume":"37","author":"R Dantzer","year":"2014","unstructured":"Dantzer R, Heijnen CJ, Kavelaars A, Laye S, Capuron L.\u00a0The neuroimmune basis of fatigue. Trends Neurosci. 2014;37:39\u201346.","journal-title":"Trends Neurosci"},{"key":"865_CR151","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1749-6632.2011.05990.x","volume":"1225","author":"AD Craig","year":"2011","unstructured":"Craig AD. Significance of the insula for the evolution of human awareness of feelings from the body. Ann N Y Acad Sci. 2011;1225:72\u201382.","journal-title":"Ann N Y Acad Sci"},{"key":"865_CR152","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nrn2555","volume":"10","author":"AD Craig","year":"2009","unstructured":"Craig AD. How do you feel\u2013now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10:59\u201370.","journal-title":"Nat Rev Neurosci"},{"key":"865_CR153","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1136\/annrheumdis-2011-201009","volume":"71","author":"JL Newton","year":"2012","unstructured":"Newton JL, Frith J, Powell D, et al. Autonomic symptoms are common and are associated with overall symptom burden and disease activity in primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2012;71:1973\u20139.","journal-title":"Ann Rheum Dis"},{"key":"865_CR154","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1093\/rheumatology\/keq042","volume":"49","author":"T Mandl","year":"2010","unstructured":"Mandl T, Hammar O, Theander E, Wollmer P, Ohlsson B.\u00a0Autonomic nervous dysfunction development in patients with primary Sj\u00f6gren\u2019s syndrome: a follow-up study. Rheumatology (Oxford). 2010;49:1101\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR155","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1503\/jpn.140217","volume":"41","author":"GA Alvares","year":"2016","unstructured":"Alvares GA, Quintana DS, Hickie IB, Guastella AJ.\u00a0Autonomic nervous system dysfunction in psychiatric disorders and the impact of psychotropic medications: a systematic review and meta-analysis. J Psychiatry Neurosci. 2016;41:89\u2013104.","journal-title":"J Psychiatry Neurosci"},{"key":"865_CR156","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2019.01104","volume":"10","author":"E Brunetta","year":"2019","unstructured":"Brunetta E, Shiffer D, Mandelli P, et al. Autonomic abnormalities in patients with primary Sj\u00f6gren\u2019s syndrome - preliminary results. Front Physiol. 2019;10:1104.","journal-title":"Front Physiol"},{"key":"865_CR157","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-025-09683-w","volume":"73","author":"E God\u00ednez-Lazarini","year":"2025","unstructured":"God\u00ednez-Lazarini E, Cim\u00e9-Ak\u00e9 E, Pe\u00f1a-Ojeda M, et al. Dysautonomia as a form of presentation of primary Sj\u00f6gren\u2019s disease: a case series of six patients. Immunol Res. 2025;73:127.","journal-title":"Immunol Res"},{"issue":"1","key":"865_CR158","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210466","volume":"14","author":"V Milic","year":"2019","unstructured":"Milic V, Grujic M, Barisic J, et al. Personality, depression and anxiety in primary Sj\u00f6gren\u2019s syndrome - association with sociodemographic factors and comorbidity. PLoS ONE. 2019;14(1):e0210466. https:\/\/doi.org\/10.1371\/journal.pone.0210466.","journal-title":"PLoS ONE"},{"key":"865_CR159","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijpsycho2012.10.018","volume":"90","author":"A Bibbey","year":"2013","unstructured":"Bibbey A, Carroll D, Roseboom TJ, Phillips AC, de Rooij SR. Personality and psychological reactions to acute psychological stress. Int J Psychophysiol. 2013;90:28\u201336. https:\/\/doi.org\/10.1016\/j.ijpsycho2012.10.018.","journal-title":"Int J Psychophysiol"},{"key":"865_CR160","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3758\/BF03332017","volume":"28","author":"D Savic","year":"2000","unstructured":"Savic D, Knezevic G, Opacic G. A mathematical model of stress reaction: individual differ in treshold and duration. Psychobiology. 2000;28:581\u201392.","journal-title":"Psychobiology"},{"key":"865_CR161","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S1461145704004729","volume":"8","author":"K Demyttenaere","year":"2005","unstructured":"Demyttenaere K, De Fruyt J, Stahl SM. The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol. 2005;8:93\u2013105.","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"865_CR162","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/00006842-199307000-00004","volume":"55","author":"TB Herbert","year":"1993","unstructured":"Herbert TB, Cohen S. Stress and immunity in humans: a meta-analytic review. Psychosom Med. 1993;55(4):364\u201379.","journal-title":"Psychosom Med"},{"key":"865_CR163","first-page":"1508","volume":"25","author":"EO Johnson","year":"1998","unstructured":"Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM. Hypofunction of the stress axis in Sj\u00f6gren\u2019s syndrome. J Rheumatol. 1998;25:1508\u201314.","journal-title":"J Rheumatol"},{"key":"865_CR164","doi-asserted-by":"publisher","DOI":"10.1177\/13872877261442229","author":"M Bandaru","year":"2026","unstructured":"Bandaru M, Rainier A, Islam MA, Reddy PH. Behavioral consequences of serotonin deficiency in TPH2 knock-in mice: Implications for depression, anxiety, and cognitive dysfunction. J Alzheimer\u2019s Dis. 2026. https:\/\/doi.org\/10.1177\/13872877261442229.","journal-title":"J Alzheimer's Dis."},{"key":"865_CR165","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ejca.2007.11.023","volume":"44","author":"A Jager","year":"2008","unstructured":"Jager A, Sleijfer S, van der Rijt CC. The pathogenesis of cancer related fatigue: could increased activity of pro-inflammatory cytokines be the common denominator? Eur J Cancer. 2008;44:175\u201381.","journal-title":"Eur J Cancer"},{"issue":"1","key":"865_CR166","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s40744-022-00493-2","volume":"10","author":"K Raymond","year":"2023","unstructured":"Raymond K, Maher S, Saucier CD, et al. Validation of the PROFAD-SSI-SF in patients with primary Sj\u00f6gren\u2019s syndrome with organ involvement: results of qualitative interviews and psychometric analyses. Rheumatol Therapy. 2023;10(1):95\u2013115. https:\/\/doi.org\/10.1007\/s40744-022-00493-2.","journal-title":"Rheumatol Therapy"},{"issue":"1","key":"865_CR167","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.jpsychores.2012.10.011","volume":"74","author":"Z Butt","year":"2013","unstructured":"Butt Z, Lai JS, Rao D, Heinemann AW, Bill A, Cella D.\u00a0Measurement of fatigue in cancer, stroke, and HIV using the Functional Assessment of Chronic Illness Therapy\u2013Fatigue (FACIT-F) scale. J Psychosom Res. 2013;74(1):64\u20138. https:\/\/doi.org\/10.1016\/j.jpsychores.2012.10.011.","journal-title":"J Psychosom Res"},{"issue":"1","key":"865_CR168","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-019-1141-x","volume":"17","author":"C Feng","year":"2019","unstructured":"Feng C, He Q, Wu Y,\u00a0et al. Psychometric properties of fatigue severity scale in Chinese systemic lupus erythematosus patients. Health Qual Life Outcomes. 2019;17(1):71. https:\/\/doi.org\/10.1186\/s12955-019-1141-x.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"865_CR169","doi-asserted-by":"publisher","DOI":"10.1186\/s12955-024-02316-0","volume":"22","author":"M Rothmund","year":"2024","unstructured":"Rothmund M, Pilz MJ, Egeter N,\u00a0et al. Comparing the contents of patient-reported outcome measures for fatigue: EORTC CAT Core, EORTC QLQ-C30, EORTC QLQ-FA12, FACIT, PRO-CTCAE, PROMIS, Brief Fatigue Inventory, Multidimensional Fatigue Inventory, and Piper Fatigue Scale. Health Qual Life Outcomes. 2024;22(1):104. https:\/\/doi.org\/10.1186\/s12955-024-02316-0.","journal-title":"Health Qual Life Outcomes"},{"issue":"13","key":"865_CR170","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1177\/09612033221127650","volume":"31","author":"CI Junker","year":"2022","unstructured":"Junker CI, Dreyer L, Duch K, Waarst Gregersen J, Kristensen S. Validation of the modified fatigue impact scale in patients with systemic lupus erythematosus. Lupus. 2022;31(13):1572\u20137. https:\/\/doi.org\/10.1177\/09612033221127650.","journal-title":"Lupus"},{"issue":"1","key":"865_CR171","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2025.2524087","volume":"57","author":"L Krakau","year":"2025","unstructured":"Krakau L, Wicke F, H\u00e4user W, Beutel ME, Br\u00e4hler E, Hettich-Damm N.\u00a0Chronic fatigue: psychometric properties and updated norm values of the Chalder Fatigue Scale in a cross-sectional sample representative of the German population. Ann Med. 2025;57(1):2524087. https:\/\/doi.org\/10.1080\/07853890.2025.2524087.","journal-title":"Ann Med"},{"issue":"4","key":"865_CR172","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1002\/acr.23876","volume":"72","author":"AV Perruccio","year":"2020","unstructured":"Perruccio AV, Got M, Li S, Ye Y, Gladman DD, Chandran V.\u00a0Development of a modified psoriatic arthritis disease activity score using the medical outcomes study short form 12 as a measure of quality of life. Arthritis Care Res. 2020;72(4):577\u201382. https:\/\/doi.org\/10.1002\/acr.23876.","journal-title":"Arthritis Care Res"},{"key":"865_CR173","doi-asserted-by":"publisher","first-page":"e553","DOI":"10.1016\/S2665-9913(21)00122-3","volume":"3","author":"S Arends","year":"2021","unstructured":"Arends S, DE Wolff L, VAN Nimwegen JF, et al. Composite of relevant endpoints for Sj\u00f6gren\u2019s Syndrome (CRESS): development and validation of a novel outcome measure. Lancet Rheumatol. 2021;3:e553\u201362.","journal-title":"Lancet Rheumatol"},{"key":"865_CR174","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1136\/annrheumdis-2021-222054","volume":"81","author":"R Seror","year":"2022","unstructured":"Seror R, Baron G, Camus M, et al. Development and preliminary validation of the Sj\u00f6gren\u2019s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sj\u00f6gren\u2019s syndrome. Ann Rheum Dis. 2022;81:979\u201389.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"865_CR175","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1001\/jama.2014.7682","volume":"312","author":"JE Gottenberg","year":"2014","unstructured":"Gottenberg JE, Ravaud P, Puechal X, et al. Effects of Hydroxychloroquine on symptomatic improvement in primary Sj\u00f6gren syndrome: the JOQUER randomized clinical trial. JAMA. 2014;312(3):249\u201358. https:\/\/doi.org\/10.1001\/jama.2014.7682.","journal-title":"JAMA"},{"key":"865_CR176","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/rheumatology\/kep104","volume":"48","author":"M Rihl","year":"2009","unstructured":"Rihl M, Ulbricht K, Schmidt RE, Witte T. Treatment of sicca symptoms with hydroxychloroquine in patients with Sj\u00f6gren's syndrome. Rheumatology (Oxford). 2009;48:796\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR177","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S475605","volume":"17","author":"M Zhou","year":"2024","unstructured":"Zhou M, Dai X, Yuan F. Improved fatigue management in primary Sj\u00f6gren\u2019s syndrome: a retrospective analysis of the efficacy of methotrexate in Chinese patients. J Inflamm Res. 2024;17:7551-7560.","journal-title":"J Inflamm Res"},{"key":"865_CR178","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini C, Fulvio G, La Rocca G, Ferro F.\u00a0Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2024;20:473\u201391.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"865_CR179","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1136\/ard.2007.083865","volume":"67","author":"S Dass","year":"2008","unstructured":"Dass S, Bowman SJ, Vital EM,et al. Reduction of fatigue in Sj\u00f6gren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis. 2008;67(11):1541\u20134. https:\/\/doi.org\/10.1136\/ard.2007.083865.","journal-title":"Ann Rheum Dis"},{"key":"865_CR180","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/art.27314","volume":"62","author":"JM Meijer","year":"2010","unstructured":"Meijer JM, Meiners PM, Vissink A, et al. Effectiveness of rituximab treatment in primary Sj\u00f6gren\u2019s syndrome: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2010;62:960\u20138.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"865_CR181","doi-asserted-by":"publisher","first-page":"233","DOI":"10.7326\/M13-1085","volume":"160","author":"V Devauchelle-Pensec","year":"2014","unstructured":"Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, et al. Treatment of primary Sj\u00f6gren syndrome with Rituximab: a randomized trial. Ann Intern Med. 2014;160(4):233\u201342. https:\/\/doi.org\/10.7326\/M13-1085.","journal-title":"Ann Intern Med"},{"key":"865_CR182","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/art.40093","volume":"69","author":"SJ Bowman","year":"2017","unstructured":"Bowman SJ, Everett CC, O\u2019Dwyer JL, et al. Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 2017;69:1440\u201350.","journal-title":"Arthritis Rheumatol"},{"key":"865_CR183","doi-asserted-by":"crossref","unstructured":"Mariette X, Barone F, Baldini C, et al. A randomized, phase II study of sequential belimumab and rituximab in primary Sj\u00f6gren's syndrome. JCI Insight. 2022;7(23):e163030.","DOI":"10.1172\/jci.insight.163030"},{"key":"865_CR184","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","volume":"74","author":"X Mariette","year":"2015","unstructured":"Mariette X, Seror R, Quartuccio L, et al. Efficacy and safety of belimumab in primary Sj\u00f6gren\u2019s syndrome: results of the BELISS open-label phase II study. Ann Rheum Dis. 2015;74:526\u201331.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"865_CR185","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1136\/ard.61.6.554","volume":"61","author":"C Vitali","year":"2002","unstructured":"Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sj\u00f6gren\u2019s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61(6):554\u20138. https:\/\/doi.org\/10.1136\/ard.61.6.554.","journal-title":"Ann Rheum Dis"},{"key":"865_CR186","doi-asserted-by":"publisher","DOI":"10.1186\/ar2018","volume":"8","author":"SD Steinfeld","year":"2006","unstructured":"Steinfeld SD, Tant L, Burmester GR, et al. Epratuzumab (humanised anti-CD22 antibody) in primary Sj\u00f6gren\u2019s syndrome: an open-label phase I\/II study. Arthritis Res Ther. 2006;8:R129.","journal-title":"Arthritis Res Ther"},{"key":"865_CR187","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1136\/annrheumdis-2018-214720","volume":"78","author":"T D\u00f6rner","year":"2019","unstructured":"D\u00f6rner T, Posch MG, Li Y, et al. Treatment of primary Sj\u00f6gren\u2019s syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity. Ann Rheum Dis. 2019;78:641\u20137.","journal-title":"Ann Rheum Dis"},{"key":"865_CR188","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0140-6736(21)02251-0","volume":"399","author":"SJ Bowman","year":"2022","unstructured":"Bowman SJ, Fox R, D\u00f6rner T, et al. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sj\u00f6gren\u2019s syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial. Lancet. 2022;399:161\u201371.","journal-title":"Lancet"},{"issue":"4","key":"865_CR189","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/art.20146","volume":"50","author":"X Mariette","year":"2004","unstructured":"Mariette X, Ravaud P, Steinfeld S, et al. Inefficacy of infliximab in primary Sj\u00f6gren\u2019s syndrome: results of the randomized, controlled Trial of Remicade in Primary Sj\u00f6gren\u2019s Syndrome (TRIPSS). Arthritis Rheum. 2004;50(4):1270\u20136.","journal-title":"Arthritis Rheum"},{"issue":"7","key":"865_CR190","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1002\/art.20299","volume":"50","author":"V Sankar","year":"2004","unstructured":"Sankar V, Brennan MT, Kok MR, et al. Etanercept in Sj\u00f6gren\u2019s syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum. 2004;50(7):2240\u20135.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"865_CR191","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1136\/ard.2007.077891","volume":"67","author":"NM Moutsopoulos","year":"2008","unstructured":"Moutsopoulos NM, Katsifis GE, Angelov N, et al. Lack of efficacy of etanercept in Sj\u00f6gren syndrome correlates with failed suppression of tumour necrosis factor \u03b1 and systemic immune activation. Ann Rheum Dis. 2008;67(10):1437\u201343. https:\/\/doi.org\/10.1136\/ard.2007.077891.","journal-title":"Ann Rheum Dis"},{"issue":"19","key":"865_CR192","first-page":"1957","volume":"19","author":"T Vijmasi","year":"2013","unstructured":"Vijmasi T, Chen FYT, Chen YT, Gallup M, McNamara N. Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease. Mol Vis. 2013;19(19):1957\u201365.","journal-title":"Mol Vis"},{"issue":"1","key":"865_CR193","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/art.41489","volume":"73","author":"J Posada","year":"2021","unstructured":"Posada J, Valadkhan S, Burge D, et al. Improvement of severe fatigue following nuclease therapy in patients with primary Sj\u00f6gren\u2019s syndrome: a randomized clinical trial. Arthritis Rheumatol. 2021;73(1):143\u201350. https:\/\/doi.org\/10.1002\/art.41489.","journal-title":"Arthritis Rheumatol"},{"key":"865_CR194","doi-asserted-by":"publisher","unstructured":"Gottenberg J-E, Sivils K, Campbell K, et al. OA25 Efficacy and safety of nipocalimab, an anti-FcRn monoclonal antibody, in primary Sj\u00f6gren\u2019s disease: results from a Phase 2, multicenter, randomized, placebo-controlled, double-blind study (DAHLIAS). Rheumatology. 2025;64. https:\/\/doi.org\/10.1093\/rheumatology\/keaf142.025.","DOI":"10.1093\/rheumatology\/keaf142.025"},{"key":"865_CR195","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1038\/s41591-024-03009-3","volume":"30","author":"EW St Clair","year":"2024","unstructured":"St Clair EW, Baer AN, Ng WF, et al. CD40 ligand antagonist dazodalibep in Sj\u00f6gren\u2019s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial. Nat Med. 2024;30:1583\u201392.","journal-title":"Nat Med"},{"key":"865_CR196","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/ard-2023-224691","volume":"83","author":"T D\u00f6rner","year":"2024","unstructured":"D\u00f6rner T, Kaul M, Sz\u00e1nt\u00f3 A, et al. Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sj\u00f6gren\u2019s syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial. Ann Rheum Dis. 2024;83:360\u201371.","journal-title":"Ann Rheum Dis"},{"key":"865_CR197","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.662223","volume":"12","author":"GE Ringheim","year":"2021","unstructured":"Ringheim GE, Wampole M, Oberoi K. Bruton\u2019s tyrosine kinase (BTK) inhibitors and autoimmune diseases: making sense of BTK inhibitor specificity profiles and recent clinical trial successes and failures. Front Immunol. 2021;12:662223.","journal-title":"Front Immunol"},{"key":"865_CR198","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1093\/rheumatology\/keaa670","volume":"60","author":"MJ Barrera","year":"2021","unstructured":"Barrera MJ, Aguilera S, Castro I, et al. Tofacitinib counteracts IL-6 overexpression induced by deficient autophagy: implications in Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2021;60:1951\u201362.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR199","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12016-020-08786-6","volume":"59","author":"H You","year":"2020","unstructured":"You H, Xu D, Zhao J, et al. JAK Inhibitors: Prospects in Connective Tissue Diseases. Clin Rev Allergy Immunol. 2020;59:334\u201351.","journal-title":"Clin Rev Allergy Immunol"},{"key":"865_CR200","doi-asserted-by":"publisher","unstructured":"Garr\u00f3s N, Mallandrich M, Beirampour N, et al. Baricitinib liposomes as a new approach for the treatment of Sj\u00f6gren's syndrome. Pharmaceutics. 2022;14. https:\/\/doi.org\/10.3390\/pharmaceutics14091895.","DOI":"10.3390\/pharmaceutics14091895"},{"issue":"4","key":"865_CR201","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1002\/acr.22968","volume":"69","author":"SE Carsons","year":"2017","unstructured":"Carsons SE, Vivino FB, Parke A, et al. Treatment guidelines for rheumatologic manifestations of Sj\u00f6gren\u2019s syndrome: use of biologic agents, management of fatigue, and inflammatory musculoskeletal pain. Arthritis Care Res. 2017;69(4):517\u201327.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"865_CR202","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1186\/s13063-021-05776-7","volume":"22","author":"KD Bruun","year":"2021","unstructured":"Bruun KD, Amris K, Vaegter HB, et al. Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial. Trials. 2021;22(1):804. https:\/\/doi.org\/10.1186\/s13063-021-05776-7.","journal-title":"Trials"},{"issue":"4","key":"865_CR203","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10067-014-2517-2","volume":"33","author":"J Younger","year":"2014","unstructured":"Younger J, Parkitny L, McLain D. The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain. Clin Rheumatol. 2014;33(4):451\u20139. https:\/\/doi.org\/10.1007\/s10067-014-2517-2.","journal-title":"Clin Rheumatol"},{"key":"865_CR204","volume":"11","author":"S Zashin","year":"2019","unstructured":"Zashin S. Sj\u00f6gren\u2019s syndrome: clinical benefits of low-dose naltrexone therapy. Cureus. 2019;11:e4225.","journal-title":"Cureus"},{"issue":"7","key":"865_CR205","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.8948","volume":"12","author":"S Zashin","year":"2020","unstructured":"Zashin S. Sjogren\u2019s syndrome and clinical benefits of low-dose naltrexone therapy: additional case reports. Cureus. 2020;12(7):e8948. https:\/\/doi.org\/10.7759\/cureus.8948.","journal-title":"Cureus"},{"key":"865_CR206","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.bbi.2006.10.011","volume":"21","author":"LR Watkins","year":"2007","unstructured":"Watkins LR, Hutchinson MF, Ledeboer A, Wieseler-Frank J, Milligan ED, Maier SF. Glia as the 'bad guys\": implications for improving clinical pain control and the clinical utility of opioids. Brain Behav Immun. 2007;21:131\u201346. https:\/\/doi.org\/10.1016\/j.bbi.2006.10.011.","journal-title":"Brain Behav Immun"},{"issue":"8","key":"865_CR207","first-page":"2195","volume":"17","author":"YA Jiazhen","year":"2016","unstructured":"Jiazhen YA, Yawen ZE, Xiaomeng YA, Xiaoying PU, Juan DU. Utilization of barley functional foods for preventing chronic diseases in China. Agric Sci Technol. 2016;17(8):2195\u2013204.","journal-title":"Agric Sci Technol"},{"key":"865_CR208","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1002\/jssc.201400798","volume":"37","author":"T Chen","year":"2014","unstructured":"Chen T, Li HM, Zou DL, Du YZ, Shen YH, Li Y.\u00a0Preparation of two flavonoid glycosides with unique structures from barley seedlings by membrane separation technology and preparative high-performance liquid chromatography. J Sep Sci. 2014;37:3760\u20136.","journal-title":"J Sep Sci"},{"key":"865_CR209","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6882-1-7","volume":"1","author":"MS Donaldson","year":"2001","unstructured":"Donaldson MS, Speight N, Loomis S. Fibromyalgia syndrome improved using a mostly raw vegetarian diet: an observational study. BMC Complement Altern Med. 2001;1:7.","journal-title":"BMC Complement Altern Med"},{"issue":"5","key":"865_CR210","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/ner.12879","volume":"22","author":"J Tarn","year":"2019","unstructured":"Tarn J, Legg S, Mitchell S, Simon B, Ng WF. The effects of noninvasive Vagus Nerve stimulation on fatigue and immune responses in patients with primary Sj\u00f6gren\u2019s syndrome. Neuromodulation. 2019;22(5):580\u20135. https:\/\/doi.org\/10.1111\/ner.12879.","journal-title":"Neuromodulation"},{"key":"865_CR211","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.neurom.2022.08.461","volume":"26","author":"J Tarn","year":"2023","unstructured":"Tarn J, Evans E, Traianos E, et al. The effects of noninvasive vagus nerve stimulation on fatigue in participants with primary Sj\u00f6gren\u2019s syndrome. Neuromodulation. 2023;26:681\u20139.","journal-title":"Neuromodulation"},{"key":"865_CR212","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.brs.2020.12.004","volume":"14","author":"A Pinto","year":"2021","unstructured":"Pinto A, Piva SR, Vieira A, et al. Transcranial direct current stimulation for fatigue in patients with Sj\u00f6gren\u2019s syndrome: a randomized, double-blind pilot study. Brain Stimul. 2021;14:141\u201351.","journal-title":"Brain Stimul"},{"key":"865_CR213","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s10067-021-05977-0","volume":"41","author":"LP Dardin","year":"2022","unstructured":"Dardin LP, Garcia ABA, Minali PA, Pinto ACPN, Trevisani VFM. The effects of resistance training in patients with primary Sj\u00f6gren\u2019s syndrome. Clin Rheumatol. 2022;41:1145\u201352.","journal-title":"Clin Rheumatol"},{"key":"865_CR214","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s00296-018-4213-z","volume":"39","author":"ST Miyamoto","year":"2019","unstructured":"Miyamoto ST, Valim V, Carletti L, et al. Supervised walking improves cardiorespiratory fitness, exercise tolerance, and fatigue in women with primary Sj\u00f6gren\u2019s syndrome: a randomized-controlled trial. Rheumatol Int. 2019;39:227\u201338.","journal-title":"Rheumatol Int"},{"key":"865_CR215","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1093\/rheumatology\/kem004","volume":"46","author":"BE Str\u00f6mbeck","year":"2007","unstructured":"Str\u00f6mbeck BE, Theander E, Jacobsson LT. Effects of exercise on aerobic capacity and fatigue in women with primary Sj\u00f6gren\u2019s syndrome. Rheumatology (Oxford). 2007;46:868\u201371.","journal-title":"Rheumatology (Oxford)"},{"key":"865_CR216","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003350","author":"EJF Santos","year":"2023","unstructured":"Santos EJF, Farisogullari B, Dures E, Geenen R, Machado PM; EULAR taskforce on recommendations for the management of fatigue in people with inflammatory rheumatic diseases.\u00a0Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases. RMD Open. 2023. https:\/\/doi.org\/10.1136\/rmdopen-2023-003350.","journal-title":"RMD Open"},{"key":"865_CR217","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/j.cpr.2007.10.004","volume":"28","author":"JM Malouff","year":"2008","unstructured":"Malouff JM, Thorsteinsson EB, Rooke SE, Bhullar N, Schutte NS.\u00a0Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis. Clin Psychol Rev. 2008;28:736\u201345.","journal-title":"Clin Psychol Rev"},{"key":"865_CR218","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000190790","volume":"78","author":"MB Powers","year":"2009","unstructured":"Powers MB, Zum Vorde Sive Vording MB, Emmelkamp PM. Acceptance and commitment therapy: a meta-analytic review. Psychother Psychosom. 2009;78:73\u201380.","journal-title":"Psychother Psychosom"},{"key":"865_CR219","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/AJP.0b013e3181cf59ce","volume":"26","author":"M Johnston","year":"2010","unstructured":"Johnston M, Foster M, Shennan J, Starkey NJ, Johnson A.\u00a0The effectiveness of an acceptance and commitment therapy self-help intervention for chronic pain. Clin J Pain. 2010;26:393\u2013402.","journal-title":"Clin J Pain"},{"key":"865_CR220","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1207\/s15327558ijbm1204_9","volume":"12","author":"LE Carlson","year":"2005","unstructured":"Carlson LE, Garland SN. Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. Int J Behav Med. 2005;12:278\u201385.","journal-title":"Int J Behav Med"},{"key":"865_CR221","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.586665","volume":"7","author":"X Ye","year":"2020","unstructured":"Ye X, Chen Z, Shen Z, Chen G, Xu X.\u00a0Yoga for treating rheumatoid arthritis: a systematic review and meta-analysis. Front Med. 2020;7:586665. https:\/\/doi.org\/10.3389\/fmed.2020.586665.","journal-title":"Front Med"},{"issue":"9","key":"865_CR222","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s00296-024-05669-3","volume":"44","author":"Z Sagtaganov","year":"2024","unstructured":"Sagtaganov Z, Bekaryssova D. Complex rehabilitation of patients with rheumatoid arthritis. Rheumatol Int. 2024;44(9):1789\u201393. https:\/\/doi.org\/10.1007\/s00296-024-05669-3.","journal-title":"Rheumatol Int"},{"key":"865_CR223","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1079841","volume":"14","author":"H Wu","year":"2023","unstructured":"Wu H, Wang Q, Wen G, Wu J, Wang Y.\u00a0The effects of Tai Chi on physical function and safety in patients with rheumatoid arthritis: a systematic review and meta-analysis. Front Physiol. 2023;14:1079841. https:\/\/doi.org\/10.3389\/fphys.2023.1079841.","journal-title":"Front Physiol"},{"issue":"9","key":"865_CR224","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1002\/14651858.CD004849.pub2","volume":"9","author":"AS Mudano","year":"2019","unstructured":"Mudano AS, Tugwell P, Wells GA, Singh JA.\u00a0Tai Chi for rheumatoid arthritis. Cochrane Database Syst Rev. 2019;9(9):4849. https:\/\/doi.org\/10.1002\/14651858.CD004849.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"865_CR225","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/odi.14680","volume":"30","author":"R Liu","year":"2024","unstructured":"Liu R, Zhang Y, Li K, et al. Effect of acupuncture on regulating IL-17, TNF-\u0251 and AQPs in Sj\u00f6gren\u2019s syndrome. Oral Dis. 2024;30(1):50\u201362. https:\/\/doi.org\/10.1111\/odi.14680.","journal-title":"Oral Dis"},{"issue":"5","key":"865_CR226","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1136\/acupmed-2016-011333","volume":"35","author":"T-H Kim","year":"2017","unstructured":"Kim TH, Kang JW, Lee MS. What is lost in the acupuncture trial when using a sham intervention? Acupunct Med. 2017;35(5):384\u20136. https:\/\/doi.org\/10.1136\/acupmed-2016-011333.","journal-title":"Acupunct Med"},{"key":"865_CR227","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.834112","volume":"16","author":"T-H Kim","year":"2022","unstructured":"Kim TH, Lee MS, Birch S, Alraek T. Plausible mechanism of sham acupuncture based on biomarkers: a systematic review of randomized controlled trials. Front Neurosci. 2022;16:834112. https:\/\/doi.org\/10.3389\/fnins.2022.834112.","journal-title":"Front Neurosci"},{"issue":"1","key":"865_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.imr.2021.100725","volume":"11","author":"S Birch","year":"2022","unstructured":"Birch S, Lee MS, Kim TH, Alraek T.\u00a0Historical perspectives on using sham acupuncture in acupuncture clinical trials. Integr Med Res. 2022;11(1):100725. https:\/\/doi.org\/10.1016\/j.imr.2021.100725.","journal-title":"Integr Med Res"},{"key":"865_CR229","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-025-07410-2","author":"JM Gomes-Silva","year":"2025","unstructured":"Gomes-Silva JM, Torres CP, Teixeira LR, et al. Prospective sham-controlled trial: acupuncture for symptom-relieving in patients with Sj\u00f6gren\u2019s disease. Clin Rheumatol. 2025. https:\/\/doi.org\/10.1007\/s10067-025-07410-2.","journal-title":"Clin Rheumatol"},{"issue":"12","key":"865_CR230","doi-asserted-by":"publisher","first-page":"CD003200","DOI":"10.1002\/14651858.CD003200.pub9","volume":"12","author":"L Larun","year":"2024","unstructured":"Larun L, Brurberg KG, Odgaard-Jensen J, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2024;12(12):CD003200. https:\/\/doi.org\/10.1002\/14651858.CD003200.pub9.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"865_CR231","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1037\/ccp0000085","volume":"84","author":"A Janse","year":"2016","unstructured":"Janse A, Wiborg JF, Bleijenberg G, Tummers M, Knoop H.\u00a0The efficacy of guided self-instruction for patients with idiopathic chronic fatigue: a randomized controlled trial. J Consult Clin Psychol. 2016;84(5):377\u201388. https:\/\/doi.org\/10.1037\/ccp0000085.","journal-title":"J Consult Clin Psychol"},{"issue":"6","key":"865_CR232","first-page":"1280","volume":"29","author":"DA Williams","year":"2002","unstructured":"Williams DA, Cary MA, Groner KH, et al. Improving physical functional status in patients with fibromyalgia: a brief cognitive behavioral intervention. J Rheumatol. 2002;29(6):1280\u20136.","journal-title":"J Rheumatol"}],"container-title":["Rheumatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40744-026-00865-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40744-026-00865-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T17:14:40Z","timestamp":1785518080000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40744-026-00865-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":232,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["865"],"URL":"https:\/\/doi.org\/10.1007\/s40744-026-00865-y","relation":{},"ISSN":["2198-6576","2198-6584"],"issn-type":[{"value":"2198-6576","type":"print"},{"value":"2198-6584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Xinyao Zhou, Jinzhou Chen, Pascal Cathebras, and Martin Killian have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}